info@medtl.com    +86-512-6252 7726    +86-512-6295 6337
Instrument
Reagent
Product Category
Since its establishment in 1997, the company has consistently adhering to the public, market-oriented, customer-centric development concept, is committed to research and development, production and sales of instruments and in vitro diagnostic reagents in the field of genetic testing, molecular diagnosis.
yiqi
Instrument
Tianlong products currently cover nucleic acid extract from nanomagnetic beads, quantification of real-time fluorescencePCRMolecular detection of instruments and equipment to large automated nucleic acid detection workstations.

Reagent
The company has a variety of reagent varieties to hundreds of, serving infectious diseases, genetic diseases, tumors and precision medical testing, has become an independent research and development and production enterprise in the domestic nucleic acid molecule diagnosis.
Shiji

Committed to building a world-class molecular diagnosis company

One of the innovative leaders in domestic genetic testing, molecular diagnosis, Tianlong in order to better serve medical diagnosis, biological testing, individualized medical, food safety and inspection and quarantine, life science, medical research and medical training, etc. It has now been developed to have a company group with a number of subsidiaries such as Tianlong, Suzhou Tianlong, Wuxi Qiqi, becoming in vitro diagnostic products.+Third-party medical inspection service+The comprehensive service provider of the whole chain of hospital investment.


Suzhou Nano Garden

As the market development needs and the company's products are constantly rich, the company has established the Clinical Division, Life Science Division, Overseas Division, Hosting and Regional Building Project.

Multiple business sections such as tumor individualization drug project department.


A Professional Medical And Health Industry Integrated Service Provider

Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands.

Experience

In 2012, the world's 57-bit SK multinational group of SK multinational companies were obtained. In 2018, he received a strategic investment in Shanghai Bihua Biological Engineering Co., Ltd. (Stock Code: 002022).
 

Core Technology

Tianlong has several major technical platforms such as PCR technology, gene chip technology, sequencing technology, based on the development, production and sales of various products based on the prior art platform.

Quality Assurance

More than 50 medical equipment CFDA registration certificates have been obtained, 5 CE certifications, 5 national key new product certificates, adopted ISO9001 and 13485 quality system assessments.
 

Coverage Multiple Fields

Tianlong products have made important contributions in hepatitis, AIDS, hand, foot and mouth disease, avian influenza, eugenics, food safety testing, and sudden public health incidents have been widely concerned by leaders at all levels.

Innovation

Applying for more than 20 kinds of intellectual property rights such as invention patents, and obtains six provincial and ministerial science and technology awards. , Wan Steel Minister, Deputy Minister Hou Jianguo, etc.

Professional Team

The company has built a scientific research, marketing and management team leading the industry and discipline leadership in the industry development, industrial operation, core technology and other aspects.
 
Recent News
Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands.
聚焦天隆.png
26 November 2021
Suzhou Tianlong won the honorary title of "Gazelle enterprise in 2021"!

On November 25th, Jiangsu Provincial Productivity Promotion Center released the results of the 20021 Jiangsu High-tech Zone Unicorn Enterprise and Yelong Enterprise Assessment, Suzhou Tianlong Biotechnology Co., Ltd. was selected in the \"2021 Yelong Enterprise\" list.

company.jpg
06 January 2022
Company Profile

Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands. Since its establishment in 1997, the company has consistently adhering to the public, market-oriented, customer-centric development concept, is committed to research and development, production and sales of instruments and in vitro diagnostic reagents in the field of genetic testing, molecular diagnosis. One of the innovative leaders in domestic genetic testing, molecular diagnosis, Tianlong in order to better serve medical diagnosis, biological testing, individualized medical, food safety and inspection and quarantine, life science, medical research and medical training, etc. It has now been developed to have a company group with a number of subsidiaries such as Tianlong, Suzhou Tianlong, Wuxi Qiqi, and become a comprehensive service provider of full-stranded medical health industry in vitro diagnostic products + third-party medical inspection services + hospital investment. . Tianlong takes the world's top 500 in 2012 in 2012

喜讯.png
05 January 2022
[Good News] HBV ultra high sensitive nucleic acid test kit won NMPA approved

Tianlong's wisdom family adds new members! The \"hepatitis B virus (HBV) nucleic acid test kit (PCR-fluorescent probe method) \" officially developed by Tianlong Technology \"officially won the listing of the National Drug Administration (NMPA), gaining three types of medical device registration certificates . It is worth mentioning that the reagent is a national science and technological major project undertaken by Tianlong Technology \"AIDS and viral hepatitis and other major infectious disease prevention \" - \"viral hepatitis related liver cancer population warning and stove Town kit and related The strategic transformation of equipment development \"(No. 2018ZX10732-202) is therefore a priority approval. National Temporation 20213400869 Ultra-high (emphasis) Product Advantage 1 Detection Sensitive: HBV Detection Limited to 5IU / mL, especially suitable for low viral load patients; L Quantitative precision: HBV quantitative range 15 IU / mL-1.0 × 109IU / M

Tianlong Technology is based on market-oriented, and has been based on the research and development of science and technology, and pursues independent brands.

Quick Links

Instrument

Reagent

Contact Us

 5th Floor, Building 7, Nishi City, Nam City, Nam City, Jinji Lake Avenue, Suzhou Industrial Park
 +86-512-6252 7726
 +86-512-6295 6337
© 2022 Suzhou Tianlong Biotechnology Co., Ltd. All rights reserved.